tradingkey.logo
tradingkey.logo
Pesquisar

Grifols SA

GRFS
Adicionar à lista de desejos
7.370USD
+0.150+2.08%
Fechamento 06/25, 16:00ETCotações atrasadas em 15 min
1.90BValor de mercado
9.50P/L TTM

Mais detalhes de Grifols SA Empresa

Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.

Informações de Grifols SA

Código da empresaGRFS
Nome da EmpresaGrifols SA
Data de listagemMay 17, 2006
CEOAbia (Jose Ignacio)
Número de funcionários23833
Tipo de títulosDepository Receipt
Fim do ano fiscalMay 17
EndereçoParque Empresarial Can Sant Joan
CidadeSANT CUGAT DEL VALLES
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísSpain
Código postal08174
Telefone34935710000
Sitehttps://www.grifols.com/
Código da empresaGRFS
Data de listagemMay 17, 2006
CEOAbia (Jose Ignacio)

Executivos da empresa Grifols SA

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Tomas Daga Gelabert
Mr. Tomas Daga Gelabert
Other External Director
Other External Director
--
--
Mr. Raimon Grifols Roura
Mr. Raimon Grifols Roura
Vice Chairman of the Board, Proprietary Director
Vice Chairman of the Board, Proprietary Director
--
--
Ms. Nuria Martin Barnes
Ms. Nuria Martin Barnes
Non-Member Secretary of the Board of Directors
Non-Member Secretary of the Board of Directors
--
--
Mr. Ignacio Ramal Subira
Mr. Ignacio Ramal Subira
Chief Internal Audit & Enterprise Risk Management
Chief Internal Audit & Enterprise Risk Management
--
--
Mr. David Ian Bell
Mr. David Ian Bell
Chief Corporate Affairs and Legal Officer
Chief Corporate Affairs and Legal Officer
--
--
Mr. Inigo Sanchez-Asiain Mardones
Mr. Inigo Sanchez-Asiain Mardones
Independent Director
Independent Director
--
--
Mr. Victor Grifols Deu
Mr. Victor Grifols Deu
Proprietary Director
Proprietary Director
--
--
Ms. Enriqueta Felip Font
Ms. Enriqueta Felip Font
Independent Director
Independent Director
--
--
Ms. Maria Teresa Rione Llano
Ms. Maria Teresa Rione Llano
Chief Communications Officer
Chief Communications Officer
--
--
Mr. Daniel Fleta Coit
Mr. Daniel Fleta Coit
Chief Industrial Services Officer
Chief Industrial Services Officer
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Tomas Daga Gelabert
Mr. Tomas Daga Gelabert
Other External Director
Other External Director
--
--
Mr. Raimon Grifols Roura
Mr. Raimon Grifols Roura
Vice Chairman of the Board, Proprietary Director
Vice Chairman of the Board, Proprietary Director
--
--
Ms. Nuria Martin Barnes
Ms. Nuria Martin Barnes
Non-Member Secretary of the Board of Directors
Non-Member Secretary of the Board of Directors
--
--
Mr. Ignacio Ramal Subira
Mr. Ignacio Ramal Subira
Chief Internal Audit & Enterprise Risk Management
Chief Internal Audit & Enterprise Risk Management
--
--
Mr. David Ian Bell
Mr. David Ian Bell
Chief Corporate Affairs and Legal Officer
Chief Corporate Affairs and Legal Officer
--
--
Mr. Inigo Sanchez-Asiain Mardones
Mr. Inigo Sanchez-Asiain Mardones
Independent Director
Independent Director
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Grifols SA?

Os cinco principais acionistas de Grifols SA são: Mr. Tomas Daga Gelabert

Quantas instituições possuem ações da Grifols SA (GRFS)?

Em 2026Q1, 346 instituições possuíam ações da Grifols SA, com valor de mercado aproximado de 148.94M, representando 57.68% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -8688154.00.
KeyAI